REVELATION BIOSCIENCES, INC. Noninterest Expense Investment Advisory Fees
REVELATION BIOSCIENCES, INC. (REVB) had Noninterest Expense Investment Advisory Fees of $150.00 thousand as of 2023-01-30, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NoninterestExpenseInvestmentAdvisoryFees · last filed 2024-09-23
- 2023-01-30: Noninterest Expense Investment Advisory Fees $150.00K.
- 2022-02-18: Noninterest Expense Investment Advisory Fees $5.30M; Noninterest Expense Investment Advisory Fees as first filed $2.70M; Noninterest Expense Investment Advisory Fees 1 month $2.70M.
| Period end | Noninterest Expense Investment Advisory Fees | Noninterest Expense Investment Advisory Fees as first filed | Noninterest Expense Investment Advisory Fees 1 month |
|---|---|---|---|
| 2023-01-30 | $150.00K 10-K · filed 2023-03-30 | ||
| 2022-02-18 | $5.30M 10-K/A · filed 2024-09-23 | $2.70M 10-Q · filed 2022-05-16 | $2.70M 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |